Hematology NewsCAR T-cell therapy turns 10 and finally earns the word ‘cure’July 22, 2022ALLCLLCellular Therapy
Hematology News‘Superior’ CLL regimen cuts chemo in halfJune 28, 2022CLLCellular TherapyMixed TopicsGene TherapyMyelodysplastic SyndromeAML
Hematology NewsFDA approves liso-cel as second-line therapy for LBCLJune 27, 2022B Cell LymphomaMixed TopicsCellular TherapyGene TherapyCLL
Hematology NewsFDA approves new CAR T-cell treatment for multiple myelomaMarch 1, 2022Multiple MyelomaCellular Therapy
Hematology NewsEMA gives green light to new CAR T-cell therapyFebruary 3, 2022DLBCLB Cell LymphomaCellular Therapy
Hematology NewsCLL patients ‘cured’: 10 years post infusion, CAR T cells persistFebruary 3, 2022CLLALLCellular Therapy
Hematology NewsDKMS: Small nonprofit to world’s largest stem cell donor registryJanuary 21, 2022ALLCOVID-19 UpdatesMixed TopicsMultiple MyelomaDLBCLB Cell LymphomaAML
Hematology NewsNHL: As a second-line treatment in phase 3 trial, tisa-cel disappointsDecember 15, 2021Aggressive LymphomasCellular TherapyGene Therapy
Hematology NewsCAR-T in children branching out to solid tumorsMarch 4, 2021Cellular TherapyImmuno-oncologyPediatricsCNS/Brain CancerALLNeuro-oncology
Hematology NewsUsing engineered T cells reduced acute, chronic GVHDFebruary 23, 2021TransplantALLAMLB Cell LymphomaMyelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsNovel ddPCR assay precisely measures CAR T-cells after infusionFebruary 22, 2021Cellular TherapyDLBCLFollicular LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsCAR T-cell products shine in real-world setting, reveal new insightsFebruary 18, 2021Cellular TherapyDLBCLLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsExperts break down latest CAR T-cell advances in lymphomaJanuary 22, 2020B Cell LymphomaCellular TherapyImmuno-oncologyImmunotherapyLymphoma & Plasma Cell DisordersMantle Cell Lymphoma
Hematology NewsCAR T-cell therapy may worsen mental health in some patientsJanuary 21, 2020Cellular TherapyTransplantCLLTransplantationMixed TopicsLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsSeveral factors may drive recent improvements in allo-HCT outcomesJanuary 20, 2020TransplantationTransplantCellular TherapyPatient & Survivor Care
